Low Sinopharm Protection In Elderly Casts New Doubt On Chinese COVID-19 Vaccines

New Real World Study Adds To Debate

A new study in over 400 people reignites fears about the apparent low efficacy of Chinese COVID-19 vaccines, especially among the elderly, and adding to the debate around the need for booster shots.

DOUBTS OVER EFFICACY OF CHINA'S SINOPHARM COVID VACCINES
SINOPHARM VACCINE HAS LOWER EFFICACY AMONG SENIORS, LATEST STUDY SHOWS • Source: Alamy

More from COVID-19

More from Scrip